Moberg Pharma AB (publ) (MOB) — Capital Reinvestment Ratio
Moberg Pharma AB (publ) (MOB) has a Capital Reinvestment Ratio of 1.00x as of December 2025, meaning it reinvests 1% of its operating cash flow (Skr1.52 Million) in capital expenditures (Skr1.52 Million). Check MOB goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Moberg Pharma AB (publ) Capital Reinvestment Ratio (2012–2019)
This chart tracks Moberg Pharma AB (publ)'s Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see MOB cash flow conversion.
Annual Capital Reinvestment Ratio for Moberg Pharma AB (publ) (2012–2019)
Year-by-year Capital Reinvestment Ratio for Moberg Pharma AB (publ) from 2012 to 2019. See Moberg Pharma AB (publ) free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.73x | Skr3.95 Million | Skr2.87 Million | ▼ -35.8% |
| 2018 | 1.13x | Skr73.89 Million | Skr83.64 Million | ▲ +209.6% |
| 2017 | 0.37x | Skr53.82 Million | Skr19.68 Million | ▼ -74.4% |
| 2015 | 1.43x | Skr30.72 Million | Skr43.88 Million | ▲ +217.5% |
| 2014 | 0.45x | Skr16.16 Million | Skr7.27 Million | ▲ +576.8% |
| 2012 | 0.07x | Skr9.48 Million | Skr630.00K | — |